Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy and gemcitabine-docetaxel chemotherapy.

Miyagawa, Takuya; Kadono, Takafumi; Kimura, Takayuki; Saigusa, Ryosuke; Yoshizaki, Ayumi; Miyagaki, Tomomitsu; Yamada, Daisuke; Masui, Yuri; Fujita, Hideki; Sato, Shinichi

Miyagawa, Takuya; Kadono, Takafumi; Kimura, Takayuki; Saigusa, Ryosuke; Yoshizaki, Ayumi; Miyagaki, Tomomitsu; Yamada, Daisuke; Masui, Yuri; Fujita, Hideki; Sato, Shinichi.

Afiliação

Miyagawa T; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Kadono T; Department of Dermatology, St Marianna University School of Medicine, Kawasaki, Japan.
Kimura T; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Saigusa R; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Yoshizaki A; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Miyagaki T; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Yamada D; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Masui Y; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Fujita H; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.
Sato S; Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo.

J Dermatol ; 44(3): e21-e22, 2017 Mar.

Article em En | MEDLINE | ID: mdl-27988943

Assuntos

Inibidores da Angiogênese/uso terapêutico; Dermatofibrossarcoma/diagnóstico; Dermatofibrossarcoma/tratamento farmacológico; Pirimidinas/uso terapêutico; Neoplasias Cutâneas/diagnóstico; Neoplasias Cutâneas/tratamento farmacológico; Sulfonamidas/uso terapêutico; Abdome; Protocolos de Quimioterapia Combinada Antineoplásica; Dacarbazina; Desoxicitidina/análogos & derivados; Dermatofibrossarcoma/cirurgia; Docetaxel; Doxorrubicina; Resistencia a Medicamentos Antineoplásicos; Evolução Fatal; Humanos; Ifosfamida; Indazóis; Masculino; Mesna; Pessoa de Meia-Idade; Neoplasias Cutâneas/cirurgia; Gencitabina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Cutâneas / Sulfonamidas / Dermatofibrossarcoma / Inibidores da Angiogênese Limite: Humans / Male / Middle aged Idioma: En Revista: J Dermatol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google